Literature DB >> 14278818

EFFECTS OF CHLOROQUINE ON PATIENTS WITH CUTANEOUS PORPHYRIA OF THE "SYMPTOMATIC" TYPE.

G D SWEENEY, S J SAUNDERS, E B DOWDLE, L EALES.   

Abstract

Entities:  

Keywords:  AMINO ACIDS; ASPARTATE AMINOTRANSFERASE; CHLOROQUINE; CLASSIFICATION; ENZYME TESTS; EXCRETION; GLUCOSEPHOSPHATE DEHY- DROGENASE DEFICIENCY; HEPATITIS, TOXIC; LEVULINIC ACID; LIVER FUNCTION; METABOLISM; PATHOLOGY; PORPHYRIA; PORPHYRINS; PYRROLES; TOXICOLOGIC REPORT; URINE

Mesh：

Substances：

Year:  1965        PMID： 14278818      PMCID： PMC2166040          DOI： 10.1136/bmj.1.5445.1281

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  9 in total

1.  Porphyria in the Bantu and some observations on the effect of chloroquine.

Authors:  P W EMBREE
Journal:  Cent Afr J Med       Date:  1961-12

2.  Fatal acute chloroquine poisoning in children.

Authors:  H M CANN; H L VERHULST
Journal:  Pediatrics       Date:  1961-01       Impact factor: 7.124

3.  The prophyrins and the porphyrias.

Authors:  L EALES
Journal:  Annu Rev Med       Date:  1961       Impact factor: 13.739

4.  [Unusual incident in the course of treatment of cutaneous porphyria in an adult with synthetic white antipaludides].

Authors:  S TEODORESCU; A BADANIOU; G GHEORGHIU
Journal:  Dermatol Wochenschr       Date:  1959-04-25

5.  Cutaneous porphyria with porphobilinogenuria; a review and report of a case treated by chelation.

Authors:  S M WOODS; H A PETERS; S A JOHNSON
Journal:  AMA Arch Derm       Date:  1958-05

6.  The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine.

Authors:  D MAUZERALL; S GRANICK
Journal:  J Biol Chem       Date:  1956-03       Impact factor: 5.157

7.  Paper chromatography of porphyrin pigments.

Authors:  L ERIKSEN
Journal:  Scand J Clin Lab Invest       Date:  1953       Impact factor: 1.713

8.  Development of porphyria during chloroquine therapy for chronic discoid lupus erythematosus.

Authors:  I H LINDEN; C G STEFFEN; V D NEWCOMER; M CHAPMAN
Journal:  Calif Med       Date:  1954-09

9.  The spectrophotometric determination of uroporphyrin.

Authors:  C RIMINGTON; S L SVEINSSON
Journal:  Scand J Clin Lab Invest       Date:  1950       Impact factor: 1.713
  9 in total
  6 in total

Review 1.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

2.  Cutaneous hepatic porphyria and oestrogens.

Authors:  P W Copeman; D J Cripps; R Summerly
Journal:  Br Med J       Date:  1966-02-19

3.  Relapse of porphyria cutanea tarda after treatment with phlebotomy or 4-aminoquinoline antimalarials: a meta-analysis.

Authors:  H Salameh; H Sarairah; M Rizwan; Y-F Kuo; K E Anderson; A K Singal
Journal:  Br J Dermatol       Date:  2018-07-26       Impact factor: 9.302

4.  [Accident in treatment of porphyria cutanea tarda by chloroquine (Resochin) (author's transl)].

Authors:  G Goerz; T Krieg; M G Eichenauer
Journal:  Arch Dermatol Res       Date:  1976-04-21       Impact factor: 3.017

5.  Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda.

Authors:  Ashwani K Singal; Csilla Kormos-Hallberg; Chul Lee; Vaithamanithi M Sadagoparamanujam; James J Grady; Daniel H Freeman; Karl E Anderson
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-14       Impact factor: 11.382

6.  Porphyria cutanea tarda: clinical and laboratory features.

Authors:  G D Sweeney; K G Jones
Journal:  Can Med Assoc J       Date:  1979-04-07       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.